Fred R. Hirsch

Active 1976–2025

Also published as
Fred R Hirsch
223
Papers
57,212
Citations
115
h-index
215
i10-index

Citations

Citations per year for Fred R. Hirsch1963: 1 citations1968: 1 citations1971: 2 citations1975: 1 citations1976: 3 citations1977: 1 citations1978: 1 citations1979: 2 citations1980: 2 citations1981: 4 citations1982: 4 citations1983: 8 citations1984: 7 citations1985: 6 citations1986: 9 citations1987: 9 citations1988: 10 citations1989: 11 citations1990: 8 citations1991: 6 citations1992: 7 citations1993: 9 citations1994: 9 citations1995: 10 citations1996: 11 citations1997: 5 citations1998: 11 citations1999: 10 citations2000: 19 citations2001: 14 citations2002: 47 citations2003: 92 citations2004: 83 citations2005: 133 citations2006: 258 citations2007: 291 citations2008: 298 citations2009: 322 citations2010: 341 citations2011: 292 citations2012: 299 citations2013: 375 citations2014: 256 citations2015: 288 citations2016: 317 citations2017: 433 citations2018: 499 citations2019: 2,062 citations2020: 2,337 citations2021: 2,321 citations2022: 1,762 citations2023: 1,297 citations2024: 2,048 citations2025: 986 citations2026: 36 citations1964–1967: no citations, so these years are not shown1969–1970: no citations, so these years are not shown1972–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,758 citing papers, 21.1% of this breakdownChina: 4,613 citing papers, 20.4% of this breakdownItaly: 1,206 citing papers, 5.3% of this breakdownUnited Kingdom: 1,023 citing papers, 4.5% of this breakdownJapan: 1,001 citing papers, 4.4% of this breakdownGermany: 890 citing papers, 4% of this breakdownFrance: 774 citing papers, 3.4% of this breakdownSpain: 687 citing papers, 3.1% of this breakdownCanada: 608 citing papers, 2.7% of this breakdownSouth Korea: 606 citing papers, 2.7% of this breakdownNetherlands: 512 citing papers, 2.3% of this breakdownAustralia: 482 citing papers, 2.1% of this breakdown
0%21.1%Other 24%

Fields

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology22%
  • Immunology and Microbiology3.5%
  • Engineering1.7%
  • Computer Science1.3%
  • Social Sciences0.5%
  • Other3.4%

Topics

  • Lung Cancer Treatments and Mutations9.7%
  • Cancer Immunotherapy and Biomarkers8.6%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Lung Cancer Research Studies5.4%
  • Cancer Genomics and Diagnostics3.6%
  • Radiomics and Machine Learning in Medical Imaging2.5%
  • Other64.1%

Coauthors

All papers

Open in search
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Authors: , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 1,560

  2. Lung cancer: current therapies and new targeted treatments

    Authors: , , , , , , - The Lancet 2016 cited by 3,358

  3. The 2015 World Health Organization Classification of Lung Tumors

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2015 cited by 4,546

  4. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 cited by 4,843

  5. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

    Authors: , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2023 cited by 343

  6. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sacha Gnjatic, Emmanuelle Passegué, Seunghee Kim‐Schulze, Brian D. Brown, Fred R. Hirsch, Brian Kim, Thomas U. Marron, Miriam Mérad - Nature 2023 cited by 184

  7. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 cited by 541

  8. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  9. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 cited by 450

  10. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 931

  11. Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 894

  12. PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 cited by 807

  13. PD-L1 Expression in Lung Cancer

    Authors: , , , , - Journal of Thoracic Oncology 2016 cited by 492

  14. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  15. New promises and challenges in the treatment of advanced non-small-cell lung cancer

    Authors: , , , , , , - The Lancet 2024 cited by 367

  16. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2022 cited by 215

  17. PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2016 cited by 1,254

  18. Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 334

  19. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 cited by 662

  20. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Yatabe, Akihiko Yoshida, Jillian B. Daigneault, Ahmet Zehir, Solange Peters, Ignacio I. Wistuba, Keith M. Kerr, John Longshore - Journal of Thoracic Oncology 2020 cited by 292

  21. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 cited by 762

  22. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean A. Fennell, Kwun M. Fong, Françoise Galateau-Sallé, Oliver Gautschi, Ritu R. Gill, Dorothy J. Giroux, Meredith Giuliani, Jin Mo Goo, Seiki Hasegawa, Fred R. Hirsch, Hans Hoffman, Wayne L. Hofstetter, James Huang, Philippe Joubert, Kemp H. Kernstine, Keith M. Kerr, Young Tae Kim, Dong Kwan Kim, Hedy L. Kindler, Yolande Lievens, Hui Liu, Donald E. Low, Gustavo Lyons, Heber MacMahon, Alyson Mahar, Mirella Marino, Edith M. Marom, José-María Matilla, Jan P. van Meerbeeck, Luis M. Montuenga, Andrew G. Nicholson, Katie Nishimura, Anna K. Nowak, Isabelle Opitz, Meinoshin Okumura, Raymond U. Osarogiagbon, Harvey I. Pass, Marc de Perrot, Helmut Prosch, David C. Rice, Andreas Rimner, Adam Rosenthal, Enrico Ruffini, Shuji Sakai, Paul Van Schil, Navneet Singh, Francisco Suárez, Ricardo Mingarini Terra, William D. Travis, Ming‐Sound Tsao, Paula A. Ugalde, Shun‐ichi Watanabe, Ignacio I. Wistuba, Murry W. Wynes, Yasushi Yatabe - Journal of Thoracic Oncology 2023 cited by 131

  23. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 cited by 106

  24. TIM-3, a promising target for cancer immunotherapy

    Authors: , , , , , - OncoTargets and Therapy 2018 cited by 236